c.niemel
TL3 Regular · Pau, FR
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 13 January 2025 · last posted 15h
148 posts, newest first. Showing up to 150.
-
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #13 · Devices › Syringes & needles · 27 Jul 2026 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #20 · Compounds › Semaglutide · 27 Jul 2026 · 20 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #23 · Clinical › Comorbidities · 27 Jul 2026 · 0 likes I read post #21 twice before replying, because I had assumed the opposite. Chronic kidney disease: compounds in this class have renal benefit in people with kidney…
-
Private prescribing in the UK: what is actually involved Replied, post #75 · Regional › UK & Ireland · 25 Jul 2026 · 0 likes I read post #73 twice before replying, because I had assumed the opposite. Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers…
-
Tracking a shortage from primary sources rather than rumour Replied, post #108 · Access › Shortages · 17 Jul 2026 · 25 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Micro-titration: a disputed topic, argued properly Replied, post #105 · Practice › Dosing & titration · 15 Jul 2026 · 7 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Journal club: LEADER as the historical anchor Replied, post #103 · Evidence › Journal club · 12 Jul 2026 · 6 likes Picking up post #100: that is the part I would want checked first. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #28 · Clinical › Comorbidities · 11 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: The best-written scientific paper you have read Replied, post #81 · Lounge › Off topic · 10 Jul 2026 · 30 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #54 · Clinical › Bloodwork · 9 Jul 2026 · 0 likes Picking up post #51: that is the part I would want checked first. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger…
-
How shortages have affected compounding permissions Replied, post #23 · Access › Shortages · 8 Jul 2026 · 0 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Comparing documentation quality across the directory, tabulated Replied, post #9 · Sourcing › Vendor reports · 8 Jul 2026 · 0 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Programming during a large energy deficit Replied, post #33 · Nutrition & Training › Resistance training · 6 Jul 2026 · 9 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #49 · Access › International · 1 Jul 2026 · 6 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Revisiting: The best-written scientific paper you have read Replied, post #62 · Lounge › Off topic · 30 Jun 2026 · 31 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Follow-up: Reading an interaction checker output critically Replied, post #25 · Practice › Interactions · 30 Jun 2026 · 32 likes Coming back to post #23, because the follow-up matters more than the original answer. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A,…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #44 · Analytics › HPLC & UHPLC · 17 Jun 2026 · 0 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Racemisation and why it is invisible to a mass measurement Replied, post #97 · Analytics › Impurities & related substances · 14 Jun 2026 · 0 likes On post #93 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #20 · Start Here › Welcome · 12 Jun 2026 · 31 likes post #19 is right about the mechanism and I think understates the practical bit. Off-topic posts that do not belong here belong in the Lounge instead. You are not in…
-
Journal club: LEADER as the historical anchor Replied, post #88 · Evidence › Journal club · 12 Jun 2026 · 2 likes post #87 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #16 · Start Here › Welcome · 11 Jun 2026 · 8 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #20 · Compounds › Secretagogues & GH axis · 9 Jun 2026 · 0 likes post #19 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #24 · Evidence › Journal club · 9 Jun 2026 · 25 likes post #23 answers the question as asked. The question underneath it is different. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Coming back to: A structured critique template this community uses Replied, post #27 · Evidence › Study critique · 6 Jun 2026 · 4 likes post #26 is right about the mechanism and I think understates the practical bit. Confounding: in observational data, is there a third variable that explains the…
-
Why this subcategory is stricter about sourcing than most Replied, post #35 · Compounds › Secretagogues & GH axis · 27 May 2026 · 0 likes Coming back to post #33, because the follow-up matters more than the original answer. IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone…
-
Prescription portability between countries Replied, post #42 · Access › International · 24 May 2026 · 7 likes post #41 is right about the mechanism and I think understates the practical bit. Currency and exchange rates: paying in different currencies has different costs and…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #38 · Practice › Storage & stability · 22 May 2026 · 1 like Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #5 · Clinical › Bloodwork · 21 May 2026 · 14 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #20 · Evidence › Journal club · 15 May 2026 · 2 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #110 · Devices › Syringes & needles · 11 May 2026 · 0 likes Picking up post #107: that is the part I would want checked first. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid,…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #42 · Practice › Reconstitution · 11 May 2026 · 0 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #102 · Practice › Dosing & titration · 1 May 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #14 · Analytics › COA interpretation · 30 Apr 2026 · 2 likes I read post #12 twice before replying, because I had assumed the opposite. What fields matter on a certificate: lot number matching the vial, test date, the analytical…
-
Does a peptide degrade silently, with no visual change? Replied, post #17 · Practice › Storage & stability · 28 Apr 2026 · 27 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
CJC-1295 with and without DAC: what the modification does Replied, post #41 · Compounds › Secretagogues & GH axis · 24 Apr 2026 · 0 likes Picking up post #38: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Journal club: is percentage weight change the right endpoint? Replied, post #96 · Evidence › Journal club · 23 Apr 2026 · 10 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #98 · Sourcing › Vendor reports · 23 Apr 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #46 · Sourcing › Logistics · 19 Apr 2026 · 4 likes Picking up post #43: that is the part I would want checked first. Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is…
-
Citation sweep results: how many references did not say what was claimed Replied, post #77 · Meta › Wiki maintenance · 13 Apr 2026 · 9 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
-
List price versus negotiated price versus what you pay Replied, post #41 · Access › Pricing · 11 Apr 2026 · 17 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #36 · Evidence › Trials · 8 Apr 2026 · 0 likes This follows post #33 rather than contradicting it. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #14 · Devices › Syringes & needles · 7 Apr 2026 · 14 likes Picking up post #11: that is the part I would want checked first. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to…
-
Choosing which test to pay for, given a fixed budget Replied, post #58 · Sourcing › Independent verification · 7 Apr 2026 · 0 likes Picking up post #55: that is the part I would want checked first. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #18 · Clinical › Bloodwork · 4 Apr 2026 · 0 likes Picking up post #15: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Revisiting: Body image changing more slowly than the body Replied, post #2 · Wellbeing › Mental health · 29 Mar 2026 · 23 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #122 · Access › Pricing · 21 Mar 2026 · 1 like Coming back to post #120, because the follow-up matters more than the original answer. Subscription services and subscriptions: some online clinics bundle compounds…
-
Personal import allowances, compared — a second dataset Replied, post #86 · Access › International · 16 Mar 2026 · 26 likes post #85 is right about the mechanism and I think understates the practical bit. Import rules for personal use: what you can import for personal use depends on your…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #61 · Compounds › Repair & healing peptides · 14 Mar 2026 · 24 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: Maintainer handover: how it works Replied, post #36 · Meta › Wiki maintenance · 7 Mar 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Grapefruit: why this class is not the class that cares Replied, post #8 · Practice › Interactions · 3 Mar 2026 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Bioimpedance and hydration: why the number moves Replied, post #11 · Outcomes › Body composition · 25 Feb 2026 · 0 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Forced degradation studies: designing one that is informative Replied, post #11 · Analytics › Method validation · 24 Feb 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Measurement error in a self-reported exposure Replied, post #16 · Evidence › Study critique · 22 Feb 2026 · 0 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #17 · Compounds › Tirzepatide · 16 Feb 2026 · 15 likes This follows post #14 rather than contradicting it. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #26 · Outcomes › Body composition · 11 Feb 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #55 · Documentation › Wiki requests · 25 Jan 2026 · 0 likes post #54 is right about the mechanism and I think understates the practical bit. Format suggestions: if you think a maintained page could be clearer in its presentation…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #17 · Analytics › Mass spectrometry · 25 Jan 2026 · 16 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Revisiting: What SELECT changed about how semaglutide is discussed, and what it did not Started this topic · Compounds › Semaglutide · 23 Jan 2026 · 0 likes Revisiting: What SELECT changed about how semaglutide is discussed, and what it did not Writing it up because I had to work it out twice and would rather nobody else…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #23 · Data & Tools › Calculators · 15 Jan 2026 · 13 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #51 · Start Here › How to Ask · 11 Jan 2026 · 7 likes This follows post #48 rather than contradicting it. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three…
-
A partial dose because the pen emptied mid-injection Replied, post #105 · Practice › Administration · 10 Jan 2026 · 6 likes post #104 answers the question as asked. The question underneath it is different. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer…
-
Reading an interaction checker output critically Replied, post #88 · Practice › Interactions · 10 Jan 2026 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #10 · Clinical › Special populations · 9 Jan 2026 · 2 likes Worth separating two things that post #6 runs together. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe…
-
When to stop reading forums, including this one Replied, post #66 · Wellbeing › Mental health · 24 Dec 2025 · 0 likes post #65 is right about the mechanism and I think understates the practical bit. Body image and weight loss: large weight loss changes a person's relationship with…
-
The decimal-point error, and the habit that catches it Replied, post #84 · Practice › Reconstitution · 17 Dec 2025 · 13 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Tracking a preprint to publication: a worked example Replied, post #136 · Evidence › Preprints · 13 Dec 2025 · 0 likes post #135 answers the question as asked. The question underneath it is different. Always label it as a preprint in any discussion. A preprint is not a published trial…
-
Prescription requirements and telehealth models Replied, post #63 · Sourcing › Regulatory · 12 Dec 2025 · 14 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Prescription requirements and telehealth models Replied, post #56 · Sourcing › Regulatory · 9 Dec 2025 · 5 likes Worth separating two things that post #52 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #31 · Analytics › Method validation · 7 Dec 2025 · 0 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Amylin receptor signalling and satiety — what changed since Replied, post #2 · Pharmacology › Receptor biology · 5 Dec 2025 · 0 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
-
Journal club: the retatrutide phase 2 obesity paper Replied, post #10 · Evidence › Journal club · 24 Nov 2025 · 0 likes Picking up post #7: that is the part I would want checked first. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence…
-
LOD and LOQ: definitions people get wrong Replied, post #3 · Analytics › Method validation · 22 Nov 2025 · 22 likes Worth separating two things that the opening post runs together. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #75 · Analytics › COA interpretation · 21 Nov 2025 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Lurking for two months before posting: was that the right call? Replied, post #60 · Start Here › Welcome · 20 Nov 2025 · 1 like post #59 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
The headache that turns out to be dehydration Replied, post #59 · Nutrition & Training › Hydration & electrolytes · 16 Nov 2025 · 2 likes post #58 is right about the mechanism and I think understates the practical bit. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #6 · Compounds › Retatrutide · 16 Nov 2025 · 7 likes This follows post #3 rather than contradicting it. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #61 · Compounds › Oral incretins · 14 Nov 2025 · 1 like SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #124 · Safety › Adverse events · 12 Nov 2025 · 3 likes Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation) warrant urgent evaluation. Severe dehydration during weight loss is a…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #115 · Practice › Storage & stability · 1 Nov 2025 · 5 likes Coming back to post #113, because the follow-up matters more than the original answer. Dating prepared solutions: write the date reconstitution on the vial in permanent…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #74 · Start Here › How to Ask · 23 Oct 2025 · 0 likes post #73 answers the question as asked. The question underneath it is different. Chromatogram questions: describe the method first. Column type, gradient, wavelength,…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #8 · Practice › Side effects · 22 Oct 2025 · 1 like Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Tracking that stops updating and then resumes Replied, post #36 · Sourcing › Logistics · 15 Oct 2025 · 19 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Comparing my trajectory with the trial curves, carefully Replied, post #56 · Outcomes › Progress reports · 2 Oct 2025 · 31 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #16 · Evidence › Journal club · 26 Sep 2025 · 9 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Severe abdominal pain: why this is not a forum question — one year on Replied, post #3 · Safety › Adverse events · 24 Sep 2025 · 1 like Worth separating two things that the opening post runs together. Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #121 · Evidence › Study critique · 16 Sep 2025 · 23 likes Picking up post #118: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #74 · Devices › Cold chain · 9 Sep 2025 · 26 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #19 · Clinical › Special populations · 8 Sep 2025 · 12 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #27 · Compounds › Tirzepatide · 28 Aug 2025 · 14 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Asking about a compound your prescriber has not heard of Replied, post #136 · Clinical › Prescriber conversations · 24 Aug 2025 · 15 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #22 · Start Here › Welcome · 6 Aug 2025 · 0 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
How to research a compound with no human data without deceiving yourself Replied, post #35 · Compounds › Other compounds · 31 Jul 2025 · 30 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #86 · Compounds › Semaglutide · 25 Jul 2025 · 30 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Immortal time bias in a claims-database study Replied, post #6 · Evidence › Study critique · 25 Jul 2025 · 9 likes This follows post #3 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Why the timeline is on the right and not the left Replied, post #45 · Meta › Site feedback · 24 Jul 2025 · 0 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
A preprint whose numbers changed substantially at publication Replied, post #2 · Evidence › Preprints · 24 Jul 2025 · 28 likes This follows the opening post rather than contradicting it. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled…
-
Asking about a compound your prescriber has not heard of Replied, post #99 · Clinical › Prescriber conversations · 19 Jul 2025 · 30 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #15 · Compounds › Retatrutide · 18 Jul 2025 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #64 · Compounds › Oral incretins · 14 Jul 2025 · 1 like I read post #62 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #12 · Compounds › Secretagogues & GH axis · 6 Jul 2025 · 4 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #112 · Wellbeing › Mental health · 5 Jul 2025 · 0 likes On post #108 — agreed on the reasoning, with one qualification. Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #27 · Access › Insurance & coverage · 27 Jun 2025 · 13 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Consistent declarations and why they matter more than clever ones — a second dataset Replied, post #2 · Sourcing › Logistics · 21 Jun 2025 · 16 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Half-life, steady state, and accumulation worked through Replied, post #87 · Pharmacology › Pharmacokinetics · 9 Jun 2025 · 16 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
A claim built entirely on a subgroup analysis Replied, post #69 · Evidence › Study critique · 1 Jun 2025 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Needle changes between doses on a reusable pen Replied, post #11 · Devices › Pens & autoinjectors · 29 May 2025 · 30 likes Storage after first use: most pens can be stored at room temperature after first use, even if unrefrigerated, for a limited time (often 28 days). Check your specific…
-
Pre-registering a personal experiment, seriously Replied, post #31 · Research Methods › N-of-1 designs · 28 May 2025 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why plausible mechanism is not evidence of effect Replied, post #11 · Compounds › Repair & healing peptides · 21 May 2025 · 8 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #4 · Data & Tools › Calculators · 14 May 2025 · 0 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #14 · Compounds › Repair & healing peptides · 14 May 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #31 · Clinical › Comorbidities · 10 May 2025 · 0 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Units, standards, and other things that quietly hold the world together Replied, post #39 · Lounge › Off topic · 7 May 2025 · 28 likes post #38 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Triple agonism: additive, synergistic, or neither? Replied, post #42 · Compounds › Retatrutide · 3 May 2025 · 0 likes post #41 answers the question as asked. The question underneath it is different. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple…
-
Requesting a page: what makes a good request Replied, post #63 · Documentation › Wiki requests · 19 Apr 2025 · 0 likes I read post #61 twice before replying, because I had assumed the opposite. Suggesting content for a page: if you know a maintained page is missing something important,…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #23 · Evidence › Journal club · 18 Apr 2025 · 4 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #10 · Practice › Administration · 11 Apr 2025 · 30 likes post #9 answers the question as asked. The question underneath it is different. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller…
-
A supplier that answers analytical questions with restated claims Replied, post #54 · Sourcing › Red flags · 9 Apr 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
About the Secretagogues & GH axis category Replied, post #5 · Compounds › Secretagogues & GH axis · 2 Apr 2025 · 8 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
A certificate with no method stated: what can you conclude? Replied, post #17 · Analytics › COA interpretation · 1 Apr 2025 · 32 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #49 · Access › Insurance & coverage · 28 Mar 2025 · 4 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #35 · Analytics › COA interpretation · 28 Feb 2025 · 0 likes I read post #33 twice before replying, because I had assumed the opposite. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from…
-
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #13 · Compounds › Secretagogues & GH axis · 22 Feb 2025 · 2 likes This follows post #10 rather than contradicting it. Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #42 · Access › International · 13 Feb 2025 · 16 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Replied, post #5 · Clinical › Comorbidities · 17 Jan 2025 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Fixed versus detachable needles: the trade-offs Replied, post #107 · Devices › Syringes & needles · 12 Jan 2025 · 9 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Recovery when intake is low: what to cut first Replied, post #39 · Nutrition & Training › Resistance training · 12 Jan 2025 · 0 likes Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #145 · Practice › Dosing & titration · 9 Jan 2025 · 0 likes post #144 is right about the mechanism and I think understates the practical bit. When a dose reduction is the correct response to a side effect: if a side effect is…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #55 · Sourcing › Regulatory · 1 Jan 2025 · 20 likes Coming back to post #53, because the follow-up matters more than the original answer. Regulatory positions change: a compound's status today might differ from its…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #126 · Compounds › Oral incretins · 29 Dec 2024 · 0 likes Worth separating two things that post #122 runs together. Trial adherence in an oral trial with strict administration requirements is genuinely worse than…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #31 · Compounds › Secretagogues & GH axis · 24 Dec 2024 · 1 like post #30 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
[2026 update] New subcategory: rationale and scope Replied, post #36 · Meta › Announcements · 1 Dec 2024 · 0 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
What changed in 2026, by region Replied, post #3 · Access › International · 29 Nov 2024 · 5 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Why "any advice?" is the least effective ending for a post Replied, post #83 · Start Here › How to Ask · 28 Nov 2024 · 14 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #26 · Clinical › Special populations · 24 Nov 2024 · 7 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Washout with a one-week half-life: the arithmetic Replied, post #6 · Research Methods › N-of-1 designs · 22 Nov 2024 · 9 likes This follows post #3 rather than contradicting it. Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #40 · Compounds › Semaglutide · 8 Nov 2024 · 11 likes post #39 answers the question as asked. The question underneath it is different. The mass figure differs between sources because of how the different entities report…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #98 · Analytics › COA interpretation · 28 Oct 2024 · 12 likes Coming back to post #96, because the follow-up matters more than the original answer. When a document puts the specification in the result column, it has told you the…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #7 · Compounds › Oral incretins · 24 Oct 2024 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Fasting instructions are not optional advice. Taking the tablet with food or with…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #51 · Analytics › Method validation · 13 Oct 2024 · 2 likes post #50 is right about the mechanism and I think understates the practical bit. Accuracy: the method measures what you intend to measure. For purity methods, this is…
-
Progressive overload when the scale is falling — one year on Replied, post #149 · Nutrition & Training › Resistance training · 11 Oct 2024 · 6 likes Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #5 · Sourcing › Red flags · 11 Oct 2024 · 0 likes post #4 is right about the mechanism and I think understates the practical bit. Anonymity: a supplier that will not disclose legal name, address, or responsible person…
-
US compounding rules and how they changed Replied, post #18 · Regional › North America · 10 Oct 2024 · 6 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #4 · Access › Shortages · 8 Oct 2024 · 5 likes Picking up post #3: that is the part I would want checked first. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #61 · Clinical › Bloodwork · 27 Sep 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #44 · Compounds › Retatrutide · 18 Sep 2024 · 1 like Coming back to post #42, because the follow-up matters more than the original answer. What we do not know about retatrutide, listed explicitly: long-term safety,…
-
Blind submission and why it changes minds Replied, post #56 · Sourcing › Independent verification · 8 Sep 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How to ask for a dose change without antagonising anyone Replied, post #18 · Clinical › Prescriber conversations · 24 Aug 2024 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why I ask for the gradient before I discuss the number Replied, post #3 · Analytics › HPLC & UHPLC · 21 Jun 2024 · 0 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…